Moreover, based on the conducted analysis, no statistically significant differences were found in the percentage of T and B lymphocytes expressing the CD69 antigen in the patients with type 1 diabetes in relation to the presence of anti-EBNA-1 antibodies in the IgG class. This evidence concerns the gene CD69 and type 1 diabetes mellitus.